The platform we couldn’t find.
So we built it.

Decode Health is a precision medicine R&D company based in Nashville, TN. Our platform removes bottlenecks by combining automated multiomics and clinical analytics with proprietary patient data and deep scientific expertise to help pharma, diagnostics, and health technology teams run programs that produce results faster and with more rigor than conventional approaches allow.

Over the past decade, our team has published peer-reviewed results across both biomarker discovery and clinical decision support, spanning autoimmunity, neurodegenerative disease, oncology, infectious disease, and beyond. We’ve secured more than $2.2M in competitive NIH/NIAID SBIR funding alongside additional state matching awards, and worked with partners ranging from Fortune 500 companies to academic medical centers and patient advocacy organizations.

We run structured programs with defined phases, repeatable methodology, and IP that compounds across every engagement. The platform’s automation means we deliver at a speed and cost structure that traditional approaches cannot match, and our commercial arrangements are designed to keep our incentives aligned with yours.

One platform. Two proven applications.

Biomarker & Molecular Discovery

Multiomics analytics, including deep RNA-seq expertise, combined with clinical data to identify disease signatures, candidate biomarkers, and therapeutic targets — with recent publications in The Journal of Molecular Diagnostics, NIH/NIAID-funded.

Clinical risk prediction & decision support

Real-world claims and EHR data turned into prospectively validated ML models that identify rising-risk patients before they become high-cost — with recent publications in Communications Medicine (Nature Portfolio) and BMJ Health & Care Informatics.

Leadership

Chase Spurlock, PhD

CEO & Co-Founder

Frank Cockerill

Franklin R. Cockerill III, MD

Chief Medical Officer

Eric Thrailkill

Healthcare Growth & Strategy

Elena Grigorenko, PhD

Multiomics, Senior Scientist

Advisors

Paul Owen

Executive Advisor

Julia Polk

Co-Founder & Executive Advisor

Alan Spiro, MD, MBA

Executive Advisor
Michele Hart-Henry

Michele Hart-Henry

Executive Advisor

Board of Directors

Don Hardison Board Chairman
Chase Spurlock, PhD CEO & Co-Founder
Franklin R. Cockerill III, MD Chief Medical Officer
Julia Polk Co-Founder & Executive Advisor
Nelson Byrd Board Member

Recent Accomplishments


Four peer-reviewed publications

The Journal of Molecular Diagnostics (2024, 2025), Communications Medicine (Nature Portfolio, 2025), BMJ Health & Care Informatics (2026)

$1.9M NIH/NIAID Phase II SBIR award

One of the most selective early-stage funding mechanisms in the US (August 2025)

Scientific presentation at ACTRIMS 2026

Whole-blood RNA and plasma NfL correlations in MS and NMO to identify biomarkers and therapeutic targets (February 2026)

Ranked #86, Inc. Regionals 2024: Southeast

One of the fastest-growing private companies in the region

Industry recognition

Nashville Entrepreneur Center NEXT Award (Emerging Healthcare) and DataRobot AI Innovator Award

Data science internship program with Vanderbilt University featured in Vestigo

Building the next generation of precision medicine talent

About Us

Decode Health is a precision medicine R&D company based in Nashville, TN. Our platform removes bottlenecks by combining automated multiomics and clinical analytics with proprietary patient data and deep scientific expertise to de-risk and accelerate biomarker discovery and clinical decision support for pharma, diagnostics, and health technology partners, producing commercially structured findings in weeks rather than months.

As Seen In



Start a Discovery Sprint

Tell us about your program. We’ll follow up within one business day.